BTL Announces Expanded Clearances and Versatility for EMSELLA® Platform
TORONTO, June 5, 2025 /CNW/ -- BTL, a global leader in non-invasive medical solutions, proudly announces expanded Health Canada License for its revolutionary EMSELLA® platform, reinforcing its leadership in pelvic health and intimate wellness.
FDA-cleared and Health Canada-licensed for the treatment of urinary incontinence in both men and women, Emsella now also holds an additional Health Canada license and CE-mark certification for enhancing sexual function in patients experiencing somatic sexual arousal disorders caused by weak pelvic floor muscles.
Backed by robust clinical outcomes, EMSELLA continues to redefine non-invasive care across pelvic health and sexual function. Key findings include:
Sexual Dysfunction Statistics:
76% improvement in sexual satisfaction and desire 1
60% improvement in orgasm quality 1
37% improvement in maintaining erection during intercourse 2
48% improvement in pelvic muscle endurance 3
When compared to other modalities, EMSELLA outperforms significantly:
7x more effective than pelvic floor muscle training
"EMSELLA continues to surpass expectations—not just in treating incontinence but in restoring confidence, and overall quality of life," said David Chmel, CEO of BTL North America. "These expanded clearances and clinical outcomes validate what providers and patients have long experienced: EMSELLA delivers meaningful results in a way that's accessible, comfortable, and non-invasive."
Shari Caplan, MD, CCFP, FCFP, FAARM, a board-certified expert in functional, integrative , anti-aging, and intimate health said, "We're witnessing a complete shift in how pelvic and sexual health is approached. Patients are achieving results we used to think were only possible with surgery or years of therapy. EMSELLA has become a go-to solution in my practice for urinary control and sexual wellness for both men and women."
As the demand for intimate wellness treatments rises, EMSELLA remains uniquely positioned as an effective and versatile tool for addressing some of the most intimate and often under-discussed health concerns.
To learn more about EMSELLA, visit www.emsella.com.
About BTL
Founded in 1993, BTL is a global leader in medical devices, providing innovative solutions in dermatology, plastic surgery, med spas, orthopedics, joint and spine care, rehabilitation, dentistry, primary care, OB/GYN, and more. With 350+ patents and over 580 in-house engineers, BTL leverages technology and science to advance medical treatments. Its product portfolio includes , EMSCULPT NEO®, EMFACE®, EXION™, EXOMIND™, EMSELLA®, and others.
For more information, visit www.bodybybtl.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
3 hours ago
- Cision Canada
Innocan Pharma Announces Presentation of Narrative Review on Long-Acting Synthetic Cannabidiol for Chronic Pain at PAINWEEK Conference
, June 20, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, proudly announces that the recently published narrative review titled "Considering Long-Acting Synthetic Cannabidiol for Chronic Pain: A Narrative Review" (DOI: has been officially accepted for presentation at PAINWEEK 2025, the national conference on pain management, taking place this September in Las Vegas, Nevada. PAINWEEK is a prestigious event that brings together leading clinicians, researchers, and educators in the field of pain medicine, offering a unique platform to showcase innovative research and best practices. The narrative review, selected through a competitive peer-review process, provides important insights into the potential of synthetic cannabidiol (CBD), administered through extended-release formulations, as a well-tolerated, non-opioid analgesic alternative. Innocan is developing LPT-CBD, an innovative injectable liposomal drug product designed for the sustained release of synthetic CBD. Supported by multiple animal studies, LPT-CBD has demonstrated steady plasma CBD levels for up to four weeks, prolonged pain relief, and excellent tolerability—offering a promising alternative to current opioid medications and addressing the urgent need to reduce opioid dependency. LPT-CBD will be showcased at the PAINWEEK conference to thousands of healthcare professionals and potential pharmaceutical partners, positioning it at the forefront of groundbreaking non-opioid chronic pain management solutions. "We are honored to be included among the esteemed voices presenting at PAINWEEK this year," said Iris Bincovich, Chief Executive Officer of Innocan."This recognition underscores our commitment to advancing evidence-based pain care and contributing meaningful research to the field." About Innocan: Innocan is an innovator in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, Innocan developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of synthetic CBD for non-opioid pain management. In the wellness sector, Innocan develops and markets a wide portfolio of high-performance self-care and beauty products to promote a healthier lifestyle. Under this segment Innocan carries on business through its 60% owned subsidiary, BI Sky Global Ltd., which focuses on advanced, targeted online sales. Contact Information: For Innocan Pharma Corporation: Iris Bincovich, CEO +1 5162104025 +972-54-3012842 +442037699377 [email protected] NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE. Caution Regarding Forward-Looking Information Certain information set forth in this news release, including, without limitation, the Company's plans for human trials of its LPT-CBD platform, is forward-looking information within the meaning of applicable securities laws. By its nature, forward-looking information is subject to numerous risks and uncertainties, some of which are beyond Innocan's control. The forward-looking information contained in this news release is based on certain key expectations and assumptions made by Innocan, including expectations and assumptions concerning the anticipated benefits of the products, satisfaction of regulatory requirements in various jurisdictions and satisfactory completion of production and distribution arrangements. Forward-looking information is subject to various risks and uncertainties that could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this news release. The key risks and uncertainties include but are not limited to: global and local (national) economic, political, market and business conditions; governmental and regulatory requirements and actions by governmental authorities; and potential disruption of relationships with suppliers, manufacturers, customers, business partners and competitors. There are also risks that are inherent in the nature of product distribution, including import/export matters and the failure to obtain any required regulatory and other approvals (or to do so in a timely manner). The anticipated timeline for entry to markets may change for a number of reasons, including the inability to secure necessary regulatory requirements, or the need for additional time to conclude and/or satisfy the manufacturing and distribution arrangements. As a result of the foregoing, readers should not place undue reliance on the forward-looking information contained in this news release. A comprehensive discussion of other risks that impact Innocan can be found in Innocan's public reports and filings which are available under Innocan's profile at Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. Innocan does not undertake to update, correct or revise any forward-looking information as a result of any new information, future events or otherwise, except as may be required by applicable law.
Global News
4 hours ago
- Global News
Some Acuvue contact lenses are being recalled, Health Canada says
Health Canada says a voluntary recall has been issued by Johnson & Johnson Vision care over several models of one of its Acuvue contact lenses. A total of 13 models of the Acuvue Oasys Max 1-day Multi-Focal Contact Lenses are affected by the recall, with people advised to contact the manufacturer if more information is needed. The recall is due to a high density of microbubbles that could cause 'visual disturbances.' The microbubbles, also known as microscopic voids within the contact lens, were found in 'specific limited lots,' and Health Canada says while it poses no medical harm, it could cause visual disturbances, 'particularly in low-light conditions.' Get daily National news Get the day's top news, political, economic, and current affairs headlines, delivered to your inbox once a day. Sign up for daily National newsletter Sign Up By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy Lenses with the lot or serial number of SENOFILCON A with a varying range of prescriptions are affected by the recall, with the full list available on Health Canada's website. Story continues below advertisement The recall began on June 12, however it does not advise how many affected products there might be nor a time frame for affected lenses. Health Canada posted about the recall on June 20.
Global News
4 hours ago
- Global News
Extreme heat can turn dangerous fast. Who is most vulnerable?
Doctors and health-care experts are warning Canadians to not only look after themselves but also check on others who could be vulnerable as large parts of central Canada face a sweltering heat wave. Global News chief meteorologist Anthony Farnell says a large heat ridge or dome will build over the Ohio Valley in the U.S. and expand into southeastern Canada by the end of the weekend. Temperatures are expected to reach the low to mid-30s C and the humidex could make that feel much higher, with humidex readings potentially into the mid-40s. When heat hits those levels, the body has to work harder to keep itself cool. 'The hypothalamus acts as the thermostat and sends signals to the heart to start beating faster, sends signals to our body to breathe a little faster and that helps the blood flow to the extremities so that we can dissipate heat through radiant heat loss,' said Dr. Samantha Green, a family physician at Unity Health Toronto with expertise in climate change and health. Story continues below advertisement 'It also sends signals so that we can cool down through evaporative cooling through sweating.' What does extreme heat do to your body? Prolonged exposure to heat can impact the human body in a variety of ways. One of the most common is heat exhaustion, which can lead to heat stroke. Heat exhaustion is characterized by headache, dizziness, extreme thirst, heavy sweating, muscle cramps and nausea and vomiting, according to Health Canada, and people are advised to immediately move to a cool place and drink water if experiencing these symptoms. If left untreated, that exhaustion can become heat stroke, which is defined by Johns Hopkins Medicine as the body being overwhelmed by excessive heat. Those suffering from heat stroke often have an internal temperature of 40 C or higher, warm, dry skin, confusion and nausea, and it can lead to worse conditions, including seizures, coma and even death. Story continues below advertisement While people will keep an eye on the temperature, studies show that people should also be aware of the 'wet bulb' temperature — when both humidity and air temperatures are high, it can be harder to shed heat and keep yourself cool. A 2010 study found that a wet-bulb temperature of 35 C that lasts longer than six hours could cause serious health impacts or even death. Get weekly health news Receive the latest medical news and health information delivered to you every Sunday. Sign up for weekly health newsletter Sign Up By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy A study in the Journal of Applied Physiology in 2022 found that at 100 per cent humidity, the threshold could be as low as 31 C, while at 38 C, just 60 per cent humidity could be too much for the body. 4:47 Summer can be a dangerous time for our furry friends If you are suffering from heat stroke or you notice someone with similar symptoms, move to a cool place to rest and call 911, as it is a life-threatening medical emergency. Story continues below advertisement 'If you don't feel well from the heat, seek medical attention or call 911. Don't be afraid to ask for help,' said Caroline Metz, managing director of climate resilience and health at the Intact Centre on Climate Adaptation at the University of Waterloo. Vulnerable populations, such as youth and older adults or those with chronic conditions, may find it more difficult to beat the heat. Who's most at risk? Nemours Children's Health in the U.S. notes that children's bodies are still developing and may sweat at a lower rate than adults and start sweating at a higher temperature, putting them more at risk of heat-related illness. Older adults face higher risks as they may have trouble accessing cool spaces due to mobility or transportation challenges, and those living alone may be more vulnerable as a result, according to B.C. Interior Health. Story continues below advertisement Older adults, as well as other Canadians, may also have chronic underlying health conditions or be taking medication that could interfere with the body's ability to stay cool. The U.S. Centers for Disease Control and Prevention notes that those with these conditions may be less likely to respond to changes in temperature, and that those with heart disease, mental illness and obesity have a higher risk of heat-related illness. 4:08 Summer heat can be dangerous for seniors 'It's also why people with chronic health conditions are more at risk of developing heat exhaustion, heat stroke, where the body's natural cooling mechanisms break down and the core body temperature exceeds 40 degrees,' Green said. 'That's where we end up with massive inflammation and failure of organs in the body.' People taking chronic medications can also be affected. Green said beta blockers, for example, prevent the heart from beating faster in response to heat and keep the body from naturally being able to cool down. Story continues below advertisement It's not just health conditions or age that can pose vulnerabilities, however. 'Anybody who's working outside or people experiencing homelessness, they're more exposed to heat and that's a group or a population that's more at risk,' Metz said. How to protect yourself and others Metz notes that during heat waves, it's important for people to watch out for others and check in on neighbours because those living alone or socially isolated can also be vulnerable to heat. A B.C. coroner's report following the 2023 heat dome noted that 98 per cent of the 619 deaths identified as being related to heat occurred indoors, with 56 per cent of those who died living alone. 'Social cohesion or social connectedness has been shown to be a very important factor for resilience and for health during heat waves,' Metz said. Story continues below advertisement 'In fact, in some cultures where there are multi-generational families living together, it's just very natural for people to care about others … so they don't often experience the same kind of situation that we might have here in North America, where we have one generation living in a household. 'The ability to reach out, call someone, or stop by has been shown to greatly support health and well-being for people who are isolated.' She added that older adults and those living alone should reach out to other people to let them know they're on their own and are open to having someone check on them during periods of extreme weather. As a heat wave enters Ontario later this weekend, Metz said people should stay in the coolest part of their home if possible or go to a community cooling centre, wear lighter-coloured clothing if you have to go out, keep your doors and windows closed during the hottest parts of the day, and turn off items that may produce extra heat in your home. 'If you need to be out, you want to do that during the parts of the day that are the coolest,' she suggested, noting this means early mornings and late evenings.
